These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31652306)
21. Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes. Ziolo MT; Lewandowski SJ; Smith JM; Romano FD; Wahler GM Br J Pharmacol; 2003 Mar; 138(5):986-94. PubMed ID: 12642401 [TBL] [Abstract][Full Text] [Related]
22. Regulation of metabolism by cGMP. Pfeifer A; Kilić A; Hoffmann LS Pharmacol Ther; 2013 Oct; 140(1):81-91. PubMed ID: 23756133 [TBL] [Abstract][Full Text] [Related]
23. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735 [TBL] [Abstract][Full Text] [Related]
24. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest. Su J; Scholz PM; Tse J; Weiss HR Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938 [TBL] [Abstract][Full Text] [Related]
25. [Cyclic Guanosine Monophosphate as a Mediator in Processes of Stress Signaling Transduction in Higher Plants]. Dubovskaya LV; Bakakina YS; Volotovski ID Biofizika; 2015; 60(4):681-95. PubMed ID: 26394467 [TBL] [Abstract][Full Text] [Related]
26. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. Kleppisch T; Feil R Handb Exp Pharmacol; 2009; (191):549-79. PubMed ID: 19089345 [TBL] [Abstract][Full Text] [Related]
27. Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Schröder F; Klein G; Fiedler B; Bastein M; Schnasse N; Hillmer A; Ames S; Gambaryan S; Drexler H; Walter U; Lohmann SM; Wollert KC Cardiovasc Res; 2003 Nov; 60(2):268-77. PubMed ID: 14613856 [TBL] [Abstract][Full Text] [Related]
28. Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes. Wang Y; Li ZC; Zhang P; Poon E; Kong CW; Boheler KR; Huang Y; Li RA; Yao X Stem Cells; 2015 Oct; 33(10):2973-84. PubMed ID: 26269433 [TBL] [Abstract][Full Text] [Related]
29. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes. Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696 [TBL] [Abstract][Full Text] [Related]
31. Identification and Quantification of Cyclic Di-Guanosine Monophosphate and Its Linear Metabolites by Reversed-Phase LC-MS/MS. Bähre H; Kaever V Methods Mol Biol; 2017; 1657():45-58. PubMed ID: 28889285 [TBL] [Abstract][Full Text] [Related]
32. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy. Trappanese DM; Liu Y; McCormick RC; Cannavo A; Nanayakkara G; Baskharoun MM; Jarrett H; Woitek FJ; Tillson DM; Dillon AR; Recchia FA; Balligand JL; Houser SR; Koch WJ; Dell'Italia LJ; Tsai EJ Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109 [TBL] [Abstract][Full Text] [Related]
34. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652 [TBL] [Abstract][Full Text] [Related]
35. Modulation of cardiac ERG1 K(+) channels by cGMP signaling. Mewe M; Mauerhöfer M; Wulfsen I; Szlachta K; Zhou XB; Schwarz JR; Bauer CK J Mol Cell Cardiol; 2010 Jul; 49(1):48-57. PubMed ID: 20188738 [TBL] [Abstract][Full Text] [Related]
36. Sepsis affects cardiac expression of multidrug resistance protein 5 (MRP5, ABCC5), an ABC-type CGMP export pump. Meissner K; Kessler W; Meyer zu Schwabedissen HE; Schuster K; Saalfeld K; Grube M; Buck A; Jedlitschky G; Maier S; Traeger T; Mostertz J; Homuth G; Heidecke CD; Lehmann C; Kroemer HK Shock; 2007 Nov; 28(5):564-9. PubMed ID: 17589384 [TBL] [Abstract][Full Text] [Related]
37. Negative functional effects of cyclic GMP are altered by cyclic AMP phosphodiesterases in rabbit cardiac myocytes. Weiss HR; Lazar MJ; Punjabi K; Tse J; Scholz PM Eur J Pharmacol; 2003 Nov; 481(1):25-31. PubMed ID: 14637171 [TBL] [Abstract][Full Text] [Related]
38. Generation of Transgenic Mice Expressing Cytosolic and Targeted FRET Biosensors for cAMP and cGMP. Kurelić R; Nikolaev VO Methods Mol Biol; 2022; 2483():241-254. PubMed ID: 35286680 [TBL] [Abstract][Full Text] [Related]
39. Compartmentation of cAMP signalling in cardiomyocytes in health and disease. Perera RK; Nikolaev VO Acta Physiol (Oxf); 2013 Apr; 207(4):650-62. PubMed ID: 23383621 [TBL] [Abstract][Full Text] [Related]
40. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Castro LR; Schittl J; Fischmeister R Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]